Key facts
- It has raised $13.9M; the latest was Early Stage VC ($13.9M) in Jun 2025.
- Notable investors include Puhua Capital, CDH Investments, Jingjie Investment, Sanhua Group Investment, Zhejiang Transfar Company.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Rongrui Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Rongrui Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Rongrui Technology
Developer of synthetic biology-based biochemical solutions designed for industrial, pharmaceutical, and nutritional applications. The company's platform utilizes engineered microbial strains, enzyme catalysis, and AI-assisted molecular design to produce high-purity compounds such as chiral intermediates, functional lipids, and sugar substitutes, enabling manufacturers in the health, chemical, and food sectors to achieve cost-effective, scalable, and environmentally sustainable production.
- Sector
- Materials and Resources
- HQ
- Hangzhou, China
- Founded
- 2022
- Ownership
- Privately Held (backing)
Rongrui Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Rongrui Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Rongrui Technology in its N-PORT filings yet. We sweep new filings monthly.